Clinical Trials Browser

Phase 3 × Interventional × Melatonin × Clear all

NCT05502900 2025-05-15

AMUM

Phase 3 Recruiting

Uveal Melanoma

NCT01906866 2024-04-23

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Phase 3 Completed

125 enrolled 22 charts

Autism Spectrum Disorder, Sleep Wake Disorders, Tuberous Sclerosis, Angelman Syndrome, Parasomnias, Smith-Magenis Syndrome

NCT02332928 2023-03-30

Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy

Phase 3 Terminated

80 enrolled 15 charts

Breast Cancer - Female

NCT02454855 2022-06-13

MEQAPAG

Phase 3 Terminated

Neoplasms

NCT00668707 2021-08-03

AMPLCaRe

Phase 3 Completed

709 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04137627 2019-12-09

Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma

Phase 3 Completed

50 enrolled 15 charts

Squamous Cell Carcinoma of Head and Neck

NCT01566474 2019-09-13

Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study

Phase 3 Completed

Gastrointestinal

Barrett Esophagus

NCT01700959 2018-06-28

Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort

Phase 3 Completed

911 enrolled 15 charts

Parasomnias

NCT00513357 2012-12-11

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

Phase 3 Completed

82 enrolled 7 charts

GastrointestinalThoracic

Anorexia, Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Weight Loss